LD-2 disclosure · 2nd Quarter - Report
BIOGEN, INC.
via DLA PIPER LLP (US)
Client
- Name
- BIOGEN, INC.
- Description
- Biotechnology company.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- DLA PIPER LLP (US)
- Description
- Law firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
6 issuesPharmacy
Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies.
LobbyistsMARGARET MARTIN · MICHAEL SORENSEN · RACHEL PORTMAN · KARINA LYNCH · RICHARD BURR · MAREN MCBRIDE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
LobbyistsMARGARET MARTIN · MICHAEL SORENSEN · RACHEL PORTMAN · KARINA LYNCH · RICHARD BURR · MAREN MCBRIDE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues related to rare diseases including Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Lou Gehrig's Disease. Drug pricing and drug development policies. Screening and diagnosis. Patient affordability and access issues, including copay cards, copay accumulators, copay maximizers, coverage issues. Orphan Drug Act. Issues related to the FDA including PDUFA, drug reviews, approval pathways, and clinical trials. Policies related to value based arrangements. Issues related to the 340B program.
LobbyistsMARGARET MARTIN · MICHAEL SORENSEN · RACHEL PORTMAN · KARINA LYNCH · RICHARD BURR · MAREN MCBRIDE